Summary
Updated Aug 30, 2026
Pierre Kyme is Chief Business Officer of Armata Pharmaceuticals, Inc. (ARMP). 2 SEC Form 4 filings on record, most recently on 17 March 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Pierre Kyme has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Pierre Kyme's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- R01 Fund LP - $45.65M of SDEV open-market activity in the last 12 months
- Michael John Kazley - $45.65M of SDEV open-market activity in the last 12 months
- Martina M.D. Flammer - $44.93M of INSM open-market activity in the last 12 months
- Brian Taylor Slingsby - $43.35M of MLYS open-market activity in the last 12 months
- Saumya Sutaria - $42.66M of THC open-market activity in the last 12 months
- Brett P. Monia - $42.65M of IONS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pierre Kyme?
Pierre Kyme is a corporate insider, tracked as Chief Business Officer of Armata Pharmaceuticals, Inc. (ARMP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Pierre Kyme last file a Form 4?
The most recent primary Form 4 on record is dated 17 March 2026, one of 2 filings going back to 2026.
Where can I see all of Pierre Kyme's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pierre Kyme and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
